Journal of the Neurological Sciences
Volume 291, Issue 1 , Pages 17-21 , 15 April 2010

Clinical features of mitochondrial DNA m.3243A>G mutation in 47 Chinese families

  • Yinan Ma

      Affiliations

    • Department of Central Laboratory, Peking University First Hospital, Beijing, 100034, China
    • The first two authors contributed equally to this paper.
  • ,
  • Fang Fang

      Affiliations

    • Department of Neurology, Beijing Children's Hospital, Beijing, 100045, China
    • The first two authors contributed equally to this paper.
  • ,
  • Yanyan Cao

      Affiliations

    • Department of Central Laboratory, Peking University First Hospital, Beijing, 100034, China
  • ,
  • Yanling Yang

      Affiliations

    • Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China
  • ,
  • Liping Zou

      Affiliations

    • Department of Pediatrics, General Hospital of People's Liberation Army, Beijing, 100853, China
  • ,
  • Ying Zhang

      Affiliations

    • Department of Central Laboratory, Peking University First Hospital, Beijing, 100034, China
  • ,
  • Songtao Wang

      Affiliations

    • Department of Central Laboratory, Peking University First Hospital, Beijing, 100034, China
  • ,
  • Sainan Zhu

      Affiliations

    • Department of Statistics, Peking University First Hospital, Beijing, 100034, China
  • ,
  • Yufeng Xu

      Affiliations

    • Department of Central Laboratory, Peking University First Hospital, Beijing, 100034, China
  • ,
  • Pei Pei

      Affiliations

    • Department of Central Laboratory, Peking University First Hospital, Beijing, 100034, China
  • ,
  • Yu Qi

      Affiliations

    • Department of Central Laboratory, Peking University First Hospital, Beijing, 100034, China
    • Corresponding Author InformationCorresponding author. Department of Central Laboratory, First Hospital of Peking University, No. 8, Xishiku Street, West District, Beijing, 100034, China. Tel.: +86 10 64004838; fax: +86 10 66551036.

Received 23 October 2009 ,Revised 16 December 2009 ,Accepted 12 January 2010.

Reference 

  1. Finsterer J. Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation. Acta Neurol Scand. 2007;116:1–14
  2. Moraes C, Ciacci F, Silvestri G, Shanske S, Sciacco M, Hirano M, et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromuscul Disord. 1993;3:43–50
  3. Chae J, Hwang H, Lim B, Cheong H, Hwang Y, Kim K. Clinical features of A3243G mitochondrial tRNA mutation. Brain. 2004;26:459–462
  4. Gropman A. The neurological presentations of childhood and adult mitochondrial disease: established syndromes and phenotypic variations. Mitochondrion. 2004;4:503–520
  5. Schapira A. Mitochondrial disease. Lancet. 2006;368:70–82
  6. Chinnery PF, Turnbull DM. Mitochondrial DNA mutations in the pathogenesis of human disease. Mol Med Today. 2000;6:425–432
  7. Wittenhagen L, Shana O. Impact of disease-related mitochondrial mutations on tRNA structure and function. Trends Biochem Sci. 2003;28:605–611
  8. Uusimaa J, Moilanen J, Vainionpää L, Tapanainen P, Lindholm P, Nuutinen M, et al. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children. Ann Neurol. 2007;62:278–287
  9. Majamaa K, Turkka J, Kärppä M, Winqvist S, Hassinen I. The common MELAS mutation A3243G in mitochondrial DNA among young patients with an occipital brain infarct. Neurology. 1997;49:1331–1334
  10. Miller S, Dyhes D, Poleskey H. A simple salting out procedure for extracting DNA from human nucleated cell. Nucleic Acids Res. 1988;16:1215
  11. Boyle J, Lew A. An inexpensive alternative to glassmilk for DNA purification. Trends Genet. 1995;11:8
  12. Sproule DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci. 2008;1142:133–158
  13. Asano T, Tsukuda K, Katagiri H, Onishi Y, Sadaka H, Ono H, et al. Clinical relevance of heteroplasmic concentration of mitochondrial A3243G mutation in leukocytes. Diabetologia. 1999;42:1439–1443
  14. Frederiksen AL, Andersen PH, Kyvik KO, Jeppesen TD, Vissing J, Schwartz M. Tissue specific distribution of the 3243A->G mtDNA mutation. J Med Genet. 2006;43:671–677
  15. Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol. 1994;9:4–13
  16. Finsterer J. Overview on visceral manifestations of mitochondrial disorders. Neth J Med. 2006;64:61–71
  17. Chiyonobu T, Noda R, Yoshida M, Fujiki A, Ishii R, Nukina S, et al. Intestinal pseudo-obstruction in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) associated with phenytoin therapy. Brain Dev. 2008;30:430–433
  18. McDonnell MT, Schaefer AM, Blakely EL, McFarland R, Chinnery PF, Turnbull DM, et al. Noninvasive diagnosis of the 3243A>G mitochondrial DNA mutation using urinary epithelial cells. Eur J Hum Genet. 2004;12:778–781
  19. Ma Y, Fang F, Yang Y, Zou L, Zhang Y, Wang S, et al. The study of mitochondrial A3243G mutation in different samples. Mitochondrion. 2009;9:139–143
  20. Chinnery PF Howell N, Lightowlers RN Turnbull DM, MELAS , MERRF . The relationship between maternal mutation load and the frequency of clinically affected offspring. Brain. 1998;121:1889–1894

PII: S0022-510X(10)00038-9

doi: 10.1016/j.jns.2010.01.012

Journal of the Neurological Sciences
Volume 291, Issue 1 , Pages 17-21 , 15 April 2010